Financial News
Enlivex Therapeutics Ltd (NQ: ENLV )
1.300
+0.050
(+4.00%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Press Releases about Enlivex Therapeutics Ltd
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://www.globenewswire.com/Content/Images/intrado.png)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://ml.globenewswire.com/media/20c4355c-ab8b-45bd-b7a5-2c2cfa189c38/small/untitled-jpg.jpg)
![](https://ml.globenewswire.com/media/20c4355c-ab8b-45bd-b7a5-2c2cfa189c38/small/untitled-jpg.jpg)
![](https://ml.globenewswire.com/media/20c4355c-ab8b-45bd-b7a5-2c2cfa189c38/small/untitled-jpg.jpg)
![](https://ml.globenewswire.com/media/5656273e-e391-430c-b120-0d021f2e70b8/small/logo-png.png)
![](https://ml.globenewswire.com/media/5656273e-e391-430c-b120-0d021f2e70b8/small/logo-png.png)
![](https://ml.globenewswire.com/media/5656273e-e391-430c-b120-0d021f2e70b8/small/logo-png.png)
![](https://ml.globenewswire.com/media/5656273e-e391-430c-b120-0d021f2e70b8/small/logo-png.png)
![](https://ml.globenewswire.com/media/5656273e-e391-430c-b120-0d021f2e70b8/small/logo-png.png)
![](https://ml.globenewswire.com/media/5656273e-e391-430c-b120-0d021f2e70b8/small/logo-png.png)
![](https://ml.globenewswire.com/media/5656273e-e391-430c-b120-0d021f2e70b8/small/logo-png.png)
![](https://ml.globenewswire.com/media/5656273e-e391-430c-b120-0d021f2e70b8/small/logo-png.png)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://ml.globenewswire.com/media/5656273e-e391-430c-b120-0d021f2e70b8/small/logo-png.png)
![](https://ml.globenewswire.com/media/5656273e-e391-430c-b120-0d021f2e70b8/small/logo-png.png)
Enlivex Therapeutics Ltd. (NASDAQ: ENLV) Leading the Way in Tuesday Trading Based on Percentage Gain
January 02, 2024
Exposures
COVID-19
![](https://ml.globenewswire.com/media/5656273e-e391-430c-b120-0d021f2e70b8/small/logo-png.png)
![](https://ml.globenewswire.com/media/55509183-b8b9-4da4-ae63-92c83760b5d9/small/mdwd-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/5656273e-e391-430c-b120-0d021f2e70b8/small/logo-png.png)
Enlivex Announces Reprioritization Plan and Second Quarter 2023 Financial Results
September 11, 2023
Via GlobeNewswire
![](https://ml.globenewswire.com/media/5656273e-e391-430c-b120-0d021f2e70b8/small/logo-png.png)
Enlivex to Present at the H.C. Wainwright 25th Annual Global Investment Conference
September 07, 2023
Via GlobeNewswire
![](https://ml.globenewswire.com/media/5656273e-e391-430c-b120-0d021f2e70b8/small/logo-png.png)
![](https://ml.globenewswire.com/media/5656273e-e391-430c-b120-0d021f2e70b8/small/logo-png.png)
![](https://ml.globenewswire.com/media/5656273e-e391-430c-b120-0d021f2e70b8/small/logo-png.png)
![](https://ml.globenewswire.com/media/5656273e-e391-430c-b120-0d021f2e70b8/small/logo-png.png)
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.